Telomere length and genetics are independent colorectal tumour risk factors in an evaluation of biomarkers in normal bowel.
<h4>Background</h4> <p>Colorectal cancer (CRC) screening might be improved by using a measure of prior risk to modulate screening intensity or the faecal immunochemical test threshold. Intermediate molecular biomarkers could aid risk prediction by capturing both known and unknown...
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Kieli: | English |
| Julkaistu: |
Nature Publishing Group
2018
|